Preventing Blood Clots For Patients With Hereditary AT Deficiency
February 12, 2013
Blood Clotting Disorder With Devastating Consequences
Hereditary AT Deficiency is a blood-clotting condition affecting 1 out of 2000 to 3000 people in the United States. People with a family history of blood clots must be tested. Pregnant women with undiagnosed hereditary AT deficiency are at an even higher risk – for both mother and baby. Join Dr. Michael Paidas, and woman patient with this condition as they go close-up and personal in a discussion of this rare but potentially life-threatening condition. The Balancing Act…it’s morning TV…made for a woman.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.